This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Inventor Kai Shi
Introduction
Kai Shi is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of therapeutic agents and delivery vehicles through his innovative research. His work focuses on the development of polymers that can enhance the efficacy of treatments for various diseases.
Latest Patents
Kai Shi holds a patent for "Polymeric metformin and its use as a therapeutic agent and as a delivery vehicle." This patent describes polymers comprising Metformin residues, referred to as 'PolyMet.' These polymers serve as useful therapeutic agents, delivery vehicles, and transfection agents for nucleotides. The patent outlines methods for treating diseases or unwanted conditions by administering PolyMet as a therapeutic agent. Additionally, it provides methods for making PolyMet, showcasing its potential in medical applications.
Career Highlights
Kai Shi is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work has garnered attention for its innovative approach to drug delivery and therapeutic applications. With a focus on improving treatment methods, he continues to contribute to advancements in the medical field.
Collaborations
Some of his notable coworkers include Leaf Huang and Yi Zhao, who collaborate with him on various research projects. Their combined expertise enhances the potential impact of their work in the field of therapeutic agents.
Conclusion
Kai Shi's innovative contributions, particularly through his patent on PolyMet, highlight the importance of research in developing effective therapeutic agents. His work at the University of North Carolina at Chapel Hill continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
